PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg 116€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg 294€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  4. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  5. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  6. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  7. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  8. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  9. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  10. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  11. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  12. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  13. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  14. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  15. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  16. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  17. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  18. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  19. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  20. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  21. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  22. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  23. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  24. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  25. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  26. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  27. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  28. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  29. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  30. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  31. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  32. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  33. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  34. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  35. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  36. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  37. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  38. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  39. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  40. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  41. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  42. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  43. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  44. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  45. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  46. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  47. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  48. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  49. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  50. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  51. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  52. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  53. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  54. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  55. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  56. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  57. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  58. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  59. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  60. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  61. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  62. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  63. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  64. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  65. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  66. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  67. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  68. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  69. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  70. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  71. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  72. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  73. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  74. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  75. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  76. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  77. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  78. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  79. De Simone G, et al. 2021. Immunity. :. PubMed
  80. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  81. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  82. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  83. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  84. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  85. Vorselen D, et al. 2021. Elife. 10:. PubMed
  86. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  87. Koikawa K, et al. 2021. Cell. 184(18):4753-4771.e27. PubMed
  88. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  89. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  90. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  91. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  92. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  93. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  94. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  95. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  96. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  97. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  98. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  99. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  100. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  101. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  102. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  103. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  104. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  105. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  106. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  107. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  108. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  109. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  110. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  111. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  112. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  113. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  114. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  115. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  116. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  117. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  118. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  119. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  120. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  121. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  122. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  123. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  124. Gu H, et al. 2021. Elife. 10:. PubMed
  125. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  126. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  127. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  128. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  129. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  130. Bussey KA, et al. 2019. J Virol. 93. PubMed
  131. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  132. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  133. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  134. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  135. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
  136. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  137. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  138. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  139. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  140. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  141. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  142. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  143. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  144. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  145. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  146. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  147. Jones GS, et al. 2020. mSphere. 5:. PubMed
  148. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  149. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  150. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  151. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  152. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  153. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  154. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  155. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  156. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  157. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  158. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  159. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  160. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC, IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC, CyTOF®, IP, IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC, IHC, ICC, 3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC, IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC, CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F, 3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD11c

  • Biotin anti-mouse CD11c

  • FITC anti-mouse CD11c

  • PE anti-mouse CD11c

  • Purified anti-mouse CD11c

  • Alexa Fluor® 488 anti-mouse CD11c

  • Alexa Fluor® 647 anti-mouse CD11c

  • PE/Cyanine5 anti-mouse CD11c

  • PE/Cyanine7 anti-mouse CD11c

  • Brilliant Violet 605™ anti-mouse CD11c

  • Alexa Fluor® 700 anti-mouse CD11c

  • Pacific Blue™ anti-mouse CD11c

  • APC/Cyanine7 anti-mouse CD11c

  • PerCP/Cyanine5.5 anti-mouse CD11c

  • PerCP anti-mouse CD11c

  • Brilliant Violet 421™ anti-mouse CD11c

  • Brilliant Violet 570™ anti-mouse CD11c

  • Brilliant Violet 785™ anti-mouse CD11c

  • Brilliant Violet 510™ anti-mouse CD11c

  • Brilliant Violet 650™ anti-mouse CD11c

  • Purified anti-mouse CD11c (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD11c

  • PE/Dazzle™ 594 anti-mouse CD11c

  • Brilliant Violet 711™ anti-mouse CD11c

  • APC/Fire™ 750 anti-mouse CD11c

  • TotalSeq™-A0106 anti-mouse CD11c

  • Brilliant Violet 750™ anti-mouse CD11c

  • TotalSeq™-B0106 anti-mouse CD11c

  • TotalSeq™-C0106 anti-mouse CD11c

  • KIRAVIA Blue 520™ anti-mouse CD11c

  • Spark Blue™ 550 anti-mouse CD11c

  • Spark NIR™ 685 anti-mouse CD11c

  • Spark UV™ 387 anti-mouse CD11c

  • Spark Red™ 718 anti-mouse CD11c

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account